SCHEMBL29789651

SCHEMBL29789651

CC1(C)CCc2cccc(F)c2N1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR5A P47898 1/20 0.40
▸ ADRA2A P08913 1/20 0.37
▸ PDE7A Q13946 1/20 0.36
▸ AR P10275 9/20 0.33
▸ PGR P06401 5/20 0.33
▸ SRD5A1 P18405 1/20 0.33
▸ PKM P14618 1/20 0.32
▸ PKLR P30613 1/20 0.32
▸ AKR1B1 P15121 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ DRD3 P35462 1/20 0.31
▸ GRM5 P41594 1/20 0.30
▸ CA12 O43570 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ CA4 P22748 1/20 0.30
▸ CA7 P43166 1/20 0.30
▸ CA9 Q16790 1/20 0.30
▸ NR3C2 P08235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10840955 1.00 HTR5A (0.40) HTR5AADRA2APDE7AARPGR
SCHEMBL10839480 0.80 HTR5A (0.41) HTR5APDE7AARCA12CA1
SCHEMBL10840441 0.79 PDE7A (0.37) PDE7AARCA12CA1CA2
SCHEMBL10841141 0.79 AHR (0.43) HTR5AADRA2APDE7AAR
SCHEMBL10840425 0.78 AR (0.45) PDE7AARPGRNR3C2
SCHEMBL10841360 0.76 AR (0.33) AR
SCHEMBL6986075 0.76 HTR5A (0.45) HTR5AADRA2ADRD2DRD3
SCHEMBL29789658 0.76 HTR5A (0.45) HTR5AADRA2ADRD2DRD3
SCHEMBL10840604 0.75 KDM1A (0.34) ARDRD2
SCHEMBL756777 0.73 LIG1 (0.41) CA12CA1CA2CA4CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901652-A Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for the treatment of medical disorders 比亚尔R&D投资股份公司 2022-08-12 — — CN disclosed
EP-4031540-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 — — EP disclosed
Send feedback